Searched for
3SBIO
US pharma bets big on China to snap up potential blockbuster drugsU.S. drugmakers are increasingly licensing drug candidates from Chinese biotech firms, with 14 such deals worth up to $18.3 billion signed ...- Bristol Myers agrees up to $11.1 billion deal with BioNTech to shake up cancer immunotherapyThe deal, which includes $3.5 billion in unconditional payments, underpins BioNTech's ambition to continue a costly long-term focus on expe...
- Pfizer signs licensing deal worth about $6 billion with China's 3SBio for cancer drugPfizer and 3SBio Inc. have entered into a licensing agreement valued at approximately $6 billion for the development, manufacturing, and co...
- Load More